SAV1 and Miyoshi myopathy: To further determined whether ALKBH5 modulated SAV1 expression through its enzymatic activity, we used the drug 3-deazaadenosine (DAA) which suppress m6A methylation chemically.26 The results showed that the mRNA expression levels of SAV1 were significantly increased after DAA treatments in MM cells (Figure 5H).